Industry

— Company shares proprietary and scalable approach using human derived organoids for preclinical pharmacodynamic (PD) assessment of drugs targeting podocyte cells — — Recent preliminary data from Phase 2 study of GFB-887 in focal segmental glomerular disease (FSGS) further validate feasibility and value of using transplanted human organoids in preclinical PD studies — CAMBRIDGE, Mass.–(BUSINESS … [Read more…]

TORONTO–(BUSINESS WIRE)–LifeWorks Inc. (TSX: LWRK) will announce its 2022 second quarter results after the market close on Thursday, August 11, 2022. About LifeWorks LifeWorks is a world leader in providing digital and in-person solutions that support the total wellbeing of individuals – mental, physical, financial and social. As the trusted leader in mental health and … [Read more…]

LITTLETON, Mass.–(BUSINESS WIRE)–#CancerTreatment–Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that the first patient was treated at the David C. Pratt Cancer Center at Mercy Hospital St. Louis on July 5th with the MEVION S250i Proton Therapy System®. The new Mercy Proton … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Wearable Medical Devices Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global wearable medical devices market is expected to grow from $18.41 billion in 2021 to $22.44 billion in 2022 at a compound annual growth rate (CAGR) of 21.9%. The market is expected to grow to $49.6 billion in … [Read more…]

Paying off medical debt has forced 32% of Americans with medical debt to skip saving for retirement and 27% to stop paying other bills RIVERWOODS, Ill.–(BUSINESS WIRE)–A national survey conducted by Discover Personal Loans has found that financial stress is impacting how Americans seek and pay for medical care. As Americans find themselves living through … [Read more…]

VENLO, Netherlands–(BUSINESS WIRE)–QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the second quarter of 2022. Press release date / time: Wednesday, July 27, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time. Conference call date / time: Thursday, July 28, at 15:30 Frankfurt … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “End Stage Renal Disease Market Research Report by Treatment (Dialysis and Transplantation), Diagnosis, End-User, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The United States End Stage Renal Disease Market size was estimated at USD 7,173.99 million in 2021, USD 8,638.02 million … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Caspofungin Market Research Report 2022 (Status and Outlook)” report has been added to ResearchAndMarkets.com’s offering. The Global Caspofungin Market Size was estimated at USD 414.36 million in 2021 and is projected to reach USD 539.35 million by 2028, exhibiting a CAGR of 3.84% during the forecast period. The report provides a deep … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Allergic Rhinoconjunctivitis – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. The report provides current treatment practices, emerging drugs, Allergic Rhinoconjunctivitis market share of the individual therapies, current and forecasted Allergic Rhinoconjunctivitis market Size from 2019 to 2032 segmented by seven major markets. The report also covers … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Extracorporeal Shock Wave Therapy Devices Market Insights, Competitive Landscape and Market Forecast-2025” report has been added to ResearchAndMarkets.com’s offering. The report delivers an in-depth understanding of Extracorporeal Shock Wave Therapy Devices and the historical and forecasted Extracorporeal Shock Wave Therapy Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW. … [Read more…]